Fox Chase Cancer Center Names Rosenblum Chief of Gynecologic Oncology and Welcomes Edelson to Its Surgical Oncology Staff
PHILADELPHIA (October 2, 2001)-Fox Chase Cancer Center has appointed Norman G. Rosenblum, M.D., Ph.D., chief of gynecologic oncology in the department of surgical oncology. He joined the department in 1985.
A longtime resident of Wynnewood, Pa., Rosenblum was an active member of the Fox Chase staff until 1994. Then he joined the department of obstetrics and gynecology at the Reading Hospital and Medical Center in West Reading, Pa., where he served as chairman of gynecologic oncology. He remained an associate staff member at Fox Chase until becoming its chief of gynecologic oncology in July.
Rosenblum is also a clinical associate professor of obstetrics and gynecology at the University of Pennsylvania School of Medicine and a member of the staff of Lankenau Hospital. He has received such honors as recognition in The Best Doctors in America, International Who's Who of Professionals, and Strathmore's Who's Who.
In addition to treating women with gynecologic cancers, Rosenblum is interested in research aimed at preventing these tumors. One of his most recent research projects was a large regional study in Pennsylvania, New Jersey and Delaware known as SHARE. This study demonstrated that low-dose oral contraceptives currently on the market are just as effective as the older, high-dose preparations in protecting women from ovarian cancer.
Rosenblum is board-certified by the American Board of Obstetrics and Gynecology in general obstetrics and gynecology as well as in the subspecialty of gynecologic oncology. After receiving his bachelor's and master's degrees from Villanova University, Rosenblum earned his Ph.D. in anatomy from Thomas Jefferson University and his M.D. from Jefferson Medical College. He completed his residency in obstetrics and gynecology and a fellowship in gynecologic oncology at the Hospital of the University of Pennsylvania.
Rosenblum has published numerous articles in various journals. He also serves as an editorial reviewer for the journals Cancer, Gynecologic Oncology and the American Journal of Obstetrics and Gynecology.
A fellow of the American College of Obstetricians and Gynecologists and the American College of Surgeons, Rosenblum is active in the American Medical Association, the Society of Surgical Oncology, the Society of Gynecologic Oncologists, the American Society of Clinical Oncology, the Society of Gynecologic Surgeons, the Obstetrical Society of Philadelphia and the Association of Professors of Gynecology and Obstetrics.
"Dr. Rosenblum has proven himself to be a leader in his field in regard to both his skill as a physician and his dedication to research," said Burton L. Eisenberg, M.D., chairman of surgical oncology at Fox Chase. "Those of us who have worked with him at Fox Chase in the past welcome this opportunity to work with him as a full-time colleague."
Joining Rosenblum on the gynecologic oncology staff is Mitchell I. Edelson, M.D. Edelson, who recently moved to Bluebell, Pa., is new to Fox Chase. He was previously affiliated with the Reading Hospital and Medical Center, where he worked with Rosenblum as an attending physician in the department of obstetrics and gynecology.
After graduating magna cum laude from Amherst College, Edelson received his M.D. in 1991 from Jefferson Medical College. He completed both his internship and residency at Mount Sinai Medical Center in New York, where he served as chief administrative resident. He then held a fellowship in gynecological oncology at Brigham and Women's Hospital, Harvard Medical School in Boston.
Board-certified in general obstetrics and gynecology and in gynecologic oncology, Edelson is a fellow of the American College of Obstetricians and Gynecologists. He currently chairs its committee on patient education and serves on the editorial task force for the second edition of Precis, Oncology. He is also active in the American Medical Association, the Society of Gynecologic Oncologists, the American Society of Clinical Oncology and the Obstetrical Society of Philadelphia.
Edelson has earned recognition and awards ranging from the United States Senate Youth Leadership Award to the 1992 American Cancer Society of Schuylkill County's Cancer Fighter's Award. More recently, he received the Dianon Award of the New England Association of Gynecologic Oncologists.
"Dr. Edelson's impressive background in clinical research will enhance our research programs in the department of surgical oncology," said Eisenberg. "His expertise and experience will be a great addition to the Fox Chase staff."
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.